EFFECTIVENESS AND TOLERABILITY OF CV-3988, A SELECTIVE PAF ANTAGONIST, AFTER INTRAVENOUS ADMINISTRATION TO MAN

被引：28
|
作者：
ARNOUT, J
VANHECKEN, A
DELEPELEIRE, I
MIYAMOTO, Y
HOLMES, I
DESCHEPPER, P
VERMYLEN, J
机构：
[1] CATHOLIC UNIV LEUVEN,DEPT HUMAN BIOL,PHARMACOL LAB,B-3000 LOUVAIN,BELGIUM
[2] TAKEDA CHEM IND LTD,DIV NEW PROD PLANNING & DEV,OSAKA 532,JAPAN
[3] GH BESSELAAR ASSOCIATES,ZOLLIKON,SWITZERLAND
来源：
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1988年 / 25卷 / 04期
关键词：
D O I：
10.1111/j.1365-2125.1988.tb03328.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：445 / 451
页数：7
相关论文
共 50 条
  • [1] EFFECTIVENESS AND TOLERABILITY OF CV-3988, A SELECTIVE PAF ANTAGONIST, AFTER INTRAVENOUS ADMINISTRATION TO MAN
    ARNOUT, J
    VANHECKEN, A
    DELEPELEIRE, I
    MIYAMOTO, Y
    HOLMES, I
    DESCHEPPER, P
    VERMYLEN, J
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 20 - 20
  • [2] CV-3988 - A SPECIFIC ANTAGONIST OF PLATELET ACTIVATING FACTOR (PAF)
    TERASHITA, Z
    TSUSHIMA, S
    YOSHIOKA, Y
    NOMURA, H
    INADA, Y
    NISHIKAWA, K
    LIFE SCIENCES, 1983, 32 (17) : 1975 - 1982
  • [3] CV-3988 - A SPECIFIC ANTAGONIST OF PLATELET ACTIVATING FACTOR (PAF)
    TERASHITA, Z
    TSUSHIMA, S
    YOSHIOKA, Y
    NOMURA, H
    INADA, Y
    NISHIKAWA, K
    FOLIA PHARMACOLOGICA JAPONICA, 1984, 83 (05) : P20 - P20
  • [4] COMPARATIVE PHYSIOLOGICAL-EFFECTS OF PAF AND THE PAF ANTAGONIST CV-3988 IN NON-HUMAN PRIMATES
    HANDLEY, DA
    VANVALEN, RG
    FARLEY, C
    WINSLOW, CM
    LEE, ML
    DELILLO, AK
    DEACON, RW
    DARIES, FJ
    FRISCH, GE
    FLURY, S
    MELDEN, MK
    SAUNDERS, RN
    PROSTAGLANDINS, 1985, 30 (04): : 695 - 695
  • [5] BENEFICIAL-EFFECTS OF CV-3988, A SPECIFIC PAF ANTAGONIST, IN ENDOTOXIN AND ANAPHYLACTIC SHOCK
    NISHIKAWA, K
    PROSTAGLANDINS, 1985, 30 (04): : 715 - 715
  • [6] EFFECTS OF CV-3988, AN ANTAGONIST OF PLATELET-ACTIVATING-FACTOR (PAF), ON WASHED RABBIT PLATELETS
    COX, CP
    THROMBOSIS RESEARCH, 1986, 41 (02) : 211 - 222
  • [7] DIFFERENTIAL EFFECT OF A PAF ANTAGONIST CV-3988 ON ACTIVE AND PASSIVE ANAPHYLACTIC SHOCK IN VARIOUS MOUSE STRAINS
    ARIMURA, A
    HARADA, M
    LIPIDS, 1991, 26 (12) : 1386 - 1390
  • [8] THE EFFECTS OF PLATELET-ACTIVATING-FACTOR (PAF) AND A PAF ANTAGONIST (CV-3988) ON SMOKE-INHALATION INJURY IN AN OVINE MODEL
    IKEUCHI, H
    SAKANO, T
    SANCHEZ, J
    MASON, AD
    PRUITT, BA
    JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1992, 32 (03): : 344 - 350
  • [9] PAF ANTAGONIST CV-3988 IMPROVES CARDIAC-PERFORMANCE DURING LIVE ESCHERICHIA-COLI BACTEREMIA
    MINEI, J
    SHIRES, GT
    SHIRES, GT
    CIRCULATORY SHOCK, 1988, 24 (04) : 253 - 253
  • [10] EFFECTS OF THE PAF-ANTAGONIST TAKEDA CV-3988 ON PAF-INDUCED CHANGES IN MUCUS SECRETION AND IN RESPIRATORY AND CIRCULATORY VARIABLES IN FERRETS
    LANG, M
    HANSEN, D
    HAHN, HL
    BULLETIN EUROPEEN DE PHYSIOPATHOLOGIE RESPIRATOIRE-CLINICAL RESPIRATORY PHYSIOLOGY, 1986, 22 : S150 - S150
12345